clinical trials bpc 157 human safety adverse events The Hidden Risks of BPC‑ 157: What Patients Need to Know About Contamination and Preclinical safety evaluation of body – BPC-157 - Wikipedia

Furthermore, the research supporting systemic (injectable) GHK-Cu for tendon or joint repair in healthy humans is almost non-existent, relying entirely on animal models and anecdotal reports

BPC-157 is not a miracle compound

Its the difference between discovering something real and just chasing shadows

Microbiology 152:29192930

24 , Solloway et al

While coverage varies widely between providers, common criteria typically include chronic skin conditions resistant to conservative treatment, functional limitations affecting daily activities, documented pain related to the excess skin, and a history of attempted non-surgical management